Skip to main content
. 2023 May 17;9:40. doi: 10.1038/s41523-023-00545-y

Fig. 3. Prognostic performance of IbRiS on D1-D3.

Fig. 3

KM curve estimates for DFS for IbRiSH (red) versus IbRiSL (blue) across D1–D3 (ac), with IbRiSH demonstrating a significantly worse prognosis compared to IbRiSL on D1, D2, and D3 using two-sided log-rank approach.